Efficacy of carboplatin plus primary prophylactic filgrastim (granulocyte colony stimulating factor) in relapsed ovarian cancer: a study of the Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg

A total of 34 patients with advanced ovarian cancer, who relapsed 1–72 months after at least one first-line cisplatin-based chemotherapy protocol, were treated with carboplatin, 350mg/mq 4 weeks, with the adjunct of primary prophylactic granulocyte colony stimulating factor (G-CSF; filgrastim), 300...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anti-cancer drugs 1997-06, Vol.8 (5), p.432-435
Hauptverfasser:	Wils, J A, van Geuns, H, Wals, J, Vreeswijk, J, Lalisang, F
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antiemetics - pharmacology Antineoplastic Agents - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carboplatin - adverse effects Dose-Response Relationship, Drug Female Filgrastim Follow-Up Studies Granulocyte Colony-Stimulating Factor - administration & dosage Humans Middle Aged Ovarian Neoplasms - drug therapy Recombinant Proteins Recurrence Thrombocytopenia - complications Thrombocytopenia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!